- Home
- IMRX vs BYSI Comparison
IMRX vs BYSI Comparison
Compare IMRX & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- BYSI
- Stock Information
- Founded
- IMRX 2008
- BYSI 2010
- Country
- IMRX United States
- BYSI United States
- Employees
- IMRX N/A
- BYSI N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- IMRX Health Care
- BYSI Health Care
- Exchange
- IMRX Nasdaq
- BYSI Nasdaq
- Market Cap
- IMRX 68.4M
- BYSI 71.0M
- IPO Year
- IMRX 2021
- BYSI 2017
- Fundamental
- Price
- IMRX $2.60
- BYSI $3.15
- Analyst Decision
- IMRX Strong Buy
- BYSI
- Analyst Count
- IMRX 4
- BYSI 0
- Target Price
- IMRX $13.25
- BYSI N/A
- AVG Volume (30 Days)
- IMRX 2.4M
- BYSI 140.7K
- Earning Date
- IMRX 08-05-2025
- BYSI 08-11-2025
- Dividend Yield
- IMRX N/A
- BYSI N/A
- EPS Growth
- IMRX N/A
- BYSI N/A
- EPS
- IMRX N/A
- BYSI N/A
- Revenue
- IMRX N/A
- BYSI N/A
- Revenue This Year
- IMRX N/A
- BYSI N/A
- Revenue Next Year
- IMRX N/A
- BYSI N/A
- P/E Ratio
- IMRX N/A
- BYSI N/A
- Revenue Growth
- IMRX N/A
- BYSI N/A
- 52 Week Low
- IMRX $1.00
- BYSI $0.98
- 52 Week High
- IMRX $3.83
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- IMRX 70.10
- BYSI 72.10
- Support Level
- IMRX $1.66
- BYSI $2.73
- Resistance Level
- IMRX $2.24
- BYSI $3.44
- Average True Range (ATR)
- IMRX 0.32
- BYSI 0.33
- MACD
- IMRX 0.07
- BYSI 0.12
- Stochastic Oscillator
- IMRX 89.51
- BYSI 81.49
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.